Showing results (101-110 of 157) with videos related to
Sort By:
Pageof 16
Oncoimmunology|February 16, 2017
Tumor-infiltrating lymphocyte composition, organization and PD-1/ PD-L1 expression are linked in breast cancerLaurence Buisseret, Soizic Garaud, Alexandre de Wind, et al.Cell Reports|October 7, 2015
Principles Governing A-to-I RNA Editing in the Breast Cancer TranscriptomeDebora Fumagalli, David Gacquer, Françoise Rothé, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 30, 2008
Relationship between quantitative estrogen and progesterone receptor expression and human epidermal growth factor receptor 2 (HER-2) status with recurrence in the Arimidex, Tamoxifen, Alone or in Combination trialMitch Dowsett, Craig Allred, Jill Knox, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 17, 2017
Reliability of tumor-infiltrating lymphocyte and tertiary lymphoid structure assessment in human breast cancerLaurence Buisseret, Christine Desmedt, Soizic Garaud, et al.Breast Cancer Research : BCR|May 4, 2012
Prognostic and predictive value of TP53 mutations in node-positive breast cancer patients treated with anthracycline- or anthracycline/taxane-based adjuvant therapy: results from the BIG 02-98 phase III trialLynnette Fernández-Cuesta, Catherine Oakman, Priscila Falagan-Lotsch, et al.BMC Cancer|February 21, 2020
Retrospective analysis of the immunogenic effects of intra-arterial locoregional therapies in hepatocellular carcinoma: a rationale for combining selective internal radiation therapy (SIRT) and immunotherapyLigia Craciun, Roland de Wind, Pieter Demetter, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2024
Integrating Molecular Imaging and Transcriptomic Profiling in Advanced HER2-Positive Breast Cancer Receiving Trastuzumab Emtansine: An Analysis of the ZEPHIR Clinical TrialMattia Rediti, Danai Fimereli, Magdalena Mileva, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 18, 2020
Characterization of Stromal Tumor-infiltrating Lymphocytes and Genomic Alterations in Metastatic Lobular Breast CancerFrançois Richard, Samira Majjaj, David Venet, et al.Breast Cancer Research : BCR|June 13, 2025
Association of HER2-low with clinicopathological features in patients with early invasive lobular breast cancer: an international multicentric studyKaren Van Baelen, Ha-Linh Nguyen, François Richard, et al.The Journal of Clinical Investigation|August 19, 2021
Functional Th1-oriented T follicular helper cells that infiltrate human breast cancer promote effective adaptive immunityGrégory Noël, Mireille Langouo Fontsa, Soizic Garaud, et al.Pageof 16